NIPRO corporation, which has 115 offices in 42 countries and manufacturing facilities in Japan, Thailand, China, Brazil, USA, Indonesia, Bangladesh and India, has set up the new facility.
Yoshihiko Sano, president, NIPRO, and others will be present on the occasion. The Pune facility will be India’s first in-house Gamma Sterilisation Technology for medical devices. The project was accomplished with the support from over 50 specialised engineers from Atomic Energy Regulatory Board (AERB) who commissioned the facility.
The factory will manufacture the highest quality of artificial kidney (dialyzers), disposable syringes and needles, cannulas, IVC (Intravenous Catheters), AVF (Arterial Venous Fistulas) and BTS (Blood Tubing Sets) at affordable prices for the Indian market.
“The products manufactured in the Pune facility will comply with global quality standard for medical devices and the company intends to export some of the products to other markets,” said Sano.
Milind Pappu, managing director, NIPRO India Corporation Pvt. Ltd., said, “Pune is an ideal location for our new facility because of easy access to the Mumbai airport and proximity to the pharmaceutical industry. NIPRO expects to achieve Rs 350 crore turnover in 2013. The Pune factory currently provides employment opportunity to 800 people and expects to double it by end of 2013. NIPRO India’s facility for manufacturing artificial kidneys from synthetic fibers is the country’s most ambitious project in the Medical Device Industry. “